Medical News

RSS

Second-quarter fiscal 2009 results announced by AmexDrug

AmexDrug Corporation (OTCBB: AXRX), a vertically integrated pharmaceutical and cosmeceutical company, today announced second quarter 2009 financial results.

8 Sep 2009

3Dicon presents its business strategy and developments

3DIcon Corporation, the developer of groundbreaking three-dimension projection and display technologies, today provided a status report and announced several significant steps it is pursuing as a part of its business plan.

8 Sep 2009

Third human clinical trial of LigoCyte's norovirus vaccine started

LigoCyte Pharmaceuticals, Inc. announced today that it has initiated its third human clinical trial of its norovirus vaccine. The Phase I/II study will assess safety and immunogenicity associated with LigoCyte's investigational, nasally-delivered, dry powder vaccine in healthy adults. The study will also assess potential protection against clinical symptoms of norovirus infection by including a live virus challenge of subjects that have received either the vaccine or placebo.

8 Sep 2009

Lupus Foundation of America takes steps to address shortage of participants for clinical trial

It has been more than 50 years since the U.S. Food and Drug Administration (FDA) last approved a new medicine specifically for lupus – when Dwight D. Eisenhower was president. Existing treatments have been "borrowed" from other disorders and the risk/benefit ratio of these treatments is far from optimal. However, hope is on the horizon.

8 Sep 2009

Consumer Health Advisers raises $1.15M to expand its sales and marketing initiatives

Consumer Health Advisers, Inc. (CHA), a pioneering provider of a personal 'electronic medical home' for employees and dependents of large companies, is pleased to announce it has completed a Series A venture capital round of $1.15 million and opened a new office in Chicago, Illinois.

8 Sep 2009

Elsevier to launch new Health Sciences eBooks

Elsevier, the world's leading publisher of scientific, technical, and medical information products and services, announced today that nearly 250 health sciences titles published and/or publishing in 2009 and 2010 will be launched in October. These new eBook collections cover clinical content in clinical medicine, veterinary medicine, and health professions, furthering Elsevier's commitment to making health sciences content available electronically through ScienceDirect, its online scientific research platform.

8 Sep 2009

New technology developed to detect counterfeit drugs

University of Leicester researchers have combined crime research and space-age technology in ways that could lead to the quick detection of counterfeit pharmaceuticals in a black market currently worth an estimated $40billion per year.

8 Sep 2009

Newly established McClay Foundation to encourage healthcare research in Northern Ireland

Speaking last week Sir Allen McClay, Chairman of the Almac Group, formally announced the establishment of the McClay Foundation, a charitable trust, one of the first of its kind in Northern Ireland.

8 Sep 2009

Contraband cigarettes undermine tobacco-prevention strategies

Consumption of contraband cigarettes amongst adolescent daily smokers in Canada accounts for 17% of all cigarettes smoked by this age group, and rises to more than 25% in Ontario and Quebec. This behaviour may be undermining tobacco-prevention strategies, as they focus on taxation and minimum age restrictions to curb and prevent smoking, states an article http://www.cmaj.ca/press/cmaj090665.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

8 Sep 2009

National Health IT Week to focus on ARRA and healthcare reform

This September, Unitiv, as a partner in the advancement of health information technology, will join approximately 75 public and private sector organizations in Washington, D.C., to participate in the Fourth Annual National Health IT Week (September 21-25, 2009).

8 Sep 2009

Simple structured compounds to be synthesised for cancer treatment

Research is being carried out to design and synthesise a new generation of compounds that act on the tubulin molecule, involved in cell multiplication, through a mechanism that has not yet been used in chemotherapy. The researchers will then evaluate its anticarcinogenic potential for later application as a therapeutic treatment.

8 Sep 2009

Exhibition on history of immunology to be presented at 2nd European Congress of Immunology

An exhibition entitled "The Birth of Immunology" during the 2nd European Congress of Immunology from13th to 16th September 2009 at the main foyer of the ICC in Berlin will offer insights into the fast-paced history of immunology. Immunology has promoted medical progress since the end of the 19th century like almost no other discipline.

8 Sep 2009

Stemedica files patent application for diabetic retinopathy treatment

Stemedica Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research and manufacturing, has filed a patent application with the United States Patent and Trademark Office ("USPTO") for a proprietary methodology in the treatment for Diabetic Retinopathy.

8 Sep 2009

Researchers discover benefits of treating Alzheimer's disease with cancer drug

A drug now used to treat cancer may also be able to restore memory deficits in patients with Alzheimer's disease, according to a new study conducted by scientists at Columbia University Medical Center, which appeared in the September issue of the Journal of Alzheimer's Disease: Volume 18:1.

8 Sep 2009

Axel Ullrich receives the 2009 Dr. Paul Janssen Award for Biomedical Research

Johnson & Johnson today honored the career achievements of Axel Ullrich, Ph.D., with the 2009 Dr. Paul Janssen Award for Biomedical Research. Dr. Ullrich received this award for his scientific discoveries that led to innovative new drugs including Herceptin((R)) (trastuzumab)*, a personalized medicine therapy, which was the first to target a specific type of breast cancer.

8 Sep 2009

Recruitment for the Phase IIa clinical trial to assess CNS 7056 sedative completed by PAION

The biopharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8) today announces the successful completion of the Recruitment for the Phase IIa clinical trial assessing the new short-acting intravenous anesthetic/sedative CNS 7056 in patients undergoing endoscopy of the upper gastrointestinal tract.

8 Sep 2009

Chronic pediatric cough linked to reflux and allergies

New research shows that chronic cough in children is most often caused by gastroesophageal reflux and allergies. Researchers from Tulane University in New Orleans, LA, evaluated 40 patients aged 5 to 12 years with chronic cough (> 8 weeks in duration) with no obvious cause. Each patient underwent extensive multispecialty testing. Results showed that reflux was the single most commonly associated factor of chronic cough by itself (27.5 percent), followed by allergy (22.5 percent).

8 Sep 2009

Illegal immigrants may benefit from new health care reform bill

As President Obama addresses the nation on health care reform, a new analysis by the Center for Immigration Studies estimates that 6.6 million uninsured illegal immigrants could receive benefits under the House health reform bill (H.R. 3200). While the bill states that illegal immigrants are not eligible for the new taxpayer-funded affordability credits, there is nothing in the bill to enforce this provision.

8 Sep 2009

Azelastine and fluticasone combination for allergic rhinitis gets new lease

Meda and Cipla Ltd, a leading pharma company in India, have expanded the existing long term collaboration agreement for the combination of azelastine and fluticasone.

8 Sep 2009

Brainwave opens a new facility in Birchwood

National charity Brainwave, which provides home based therapy programmes for children with cerebral palsy and other conditions such as development delay, is opening a third Centre in Birchwood, Warrington to cope with the increasing demand for its services.

8 Sep 2009